Expanding the ubiquitin code through post-translational modification

EMBO Reports

Volumn 16, Issue 9, 2015, Pages 1071-1083

  Herhaus, Lina ^a   Dikic, Ivan ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

mitophagy; phosphorylation; post translational modification; ubiquitin

Indexed keywords

BINDING PROTEIN; GLUTAMIC ACID; GLUTAMINE; OPTN PROTEIN; PARKIN; PEPTIDES AND PROTEINS; PHOSPHOTRANSFERASE; PROTEIN AGGREGATE; PROTEIN P62; TANK BINDING KINASE 1; UBIQUITIN; UBIQUITIN PROTEIN LIGASE; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; PROTEIN KINASE;

AMYOTROPHIC LATERAL SCLEROSIS; AUTOPHAGY; AUTOPHOSPHORYLATION; BINDING AFFINITY; CONFORMATIONAL TRANSITION; CRYSTAL STRUCTURE; DEAMINATION; DEGENERATIVE DISEASE; DOPAMINERGIC NERVE CELL; HUMAN; MAMMAL CELL; MITOCHONDRION; MITOPHAGY; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEOMICS; REVIEW; SELECTIVE AUTOPHAGY; STOICHIOMETRY; UBIQUITINATION; YEAST CELL; ACETYLATION; ANIMAL; CHEMISTRY; GENETICS; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; PROTEIN TERTIARY STRUCTURE; YEAST;

ACETYLATION; AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; AUTOPHAGY; HUMANS; MITOCHONDRIAL DEGRADATION; PARKINSON DISEASE; PHOSPHORYLATION; PROTEIN KINASES; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN STRUCTURE, TERTIARY; UBIQUITIN; UBIQUITINATION; YEASTS;

EID: 84940783815     PISSN: 1469221X     EISSN: 14693178     Source Type: Journal    
DOI: 10.15252/embr.201540891     Document Type: Review

References (121)

1. Deribe YL, Pawson T, Dikic I, (2010) Post-translational modifications in signal integration. Nat Struct Mol Biol 17: 666-672
2. Varshavsky A, (2006) The early history of the ubiquitin field. Protein Sci 15: 647-654
3. Hochstrasser M, (2009) Origin and function of ubiquitin-like proteins. Nature 458: 422-429
4. Hershko A, Ciechanover A, (1998) The ubiquitin system. Annu Rev Biochem 67: 425-479
5. Schulman BA, (2011) Twists and turns in ubiquitin-like protein conjugation cascades. Protein Sci 20: 1941-1954
6. Spratt DE, Walden H, Shaw GS, (2014) RBR E3 ubiquitin ligases: New structures, new insights, new questions. Biochem J 458: 421-437
7. Ikeda F, Dikic I, (2008) Atypical ubiquitin chains: new molecular signals. 'Protein modifications: beyond the usual suspects' review series. EMBO Rep 9: 536-542
8. Komander D, Rape M, (2012) The ubiquitin code. Annu Rev Biochem 81: 203-229
9. Meyer HJ, Rape M, (2014) Enhanced protein degradation by branched ubiquitin chains. Cell 157: 910-921
10. Emmerich CH, Ordureau A, Strickson S, Arthur JS, Pedrioli PG, Komander D, Cohen P, (2013) Activation of the canonical IKK complex by K63/M1-linked hybrid ubiquitin chains. Proc Natl Acad Sci USA 110: 15247-15252
11. Husnjak K, Dikic I, (2012) Ubiquitin-binding proteins: decoders of ubiquitin-mediated cellular functions. Annu Rev Biochem 81: 291-322
12. Clague MJ, Barsukov I, Coulson JM, Liu H, Rigden DJ, Urbe S, (2013) Deubiquitylases from genes to organism. Physiol Rev 93: 1289-1315
13. Hunter T, (2007) The age of crosstalk: phosphorylation, ubiquitination, and beyond. Mol Cell 28: 730-738
14. Ito A, Kawaguchi Y, Lai CH, Kovacs JJ, Higashimoto Y, Appella E, Yao TP, (2002) MDM2-HDAC1-mediated deacetylation of p53 is required for its degradation. EMBO J 21: 6236-6245
15. Gronroos E, Hellman U, Heldin CH, Ericsson J, (2002) Control of Smad7 stability by competition between acetylation and ubiquitination. Mol Cell 10: 483-493
16. Du Z, Song J, Wang Y, Zhao Y, Guda K, Yang S, Kao HY, Xu Y, Willis J, Markowitz SD, et al, (2010) DNMT1 stability is regulated by proteins coordinating deubiquitination and acetylation-driven ubiquitination. Sci Signal 3: ra80
17. Gallagher E, Gao M, Liu YC, Karin M, (2006) Activation of the E3 ubiquitin ligase Itch through a phosphorylation-induced conformational change. Proc Natl Acad Sci USA 103: 1717-1722
18. Yang C, Zhou W, M-s J, Demydenko D, Harada Y, Zhou H, Liu Y-C, (2006) Negative regulation of the E3 ubiquitin ligase itch via Fyn-mediated tyrosine phosphorylation. Mol Cell 21: 135-141
19. Persaud A, Alberts P, Mari S, Tong J, Murchie R, Maspero E, Safi F, Moran MF, Polo S, Rotin D, (2014) Tyrosine phosphorylation of NEDD4 activates its ubiquitin ligase activity. Sci Signal 7: ra95
20. Huang OW, Ma X, Yin J, Flinders J, Maurer T, Kayagaki N, Phung Q, Bosanac I, Arnott D, Dixit VM, et al, (2012) Phosphorylation-dependent activity of the deubiquitinase DUBA. Nat Struct Mol Biol 19: 171-175
21. Grabbe C, Husnjak K, Dikic I, (2011) The spatial and temporal organization of ubiquitin networks. Nat Rev Mol Cell Biol 12: 295-307
22. Wu G, Xu G, Schulman BA, Jeffrey PD, Harper JW, Pavletich NP, (2003) Structure of a beta-TrCP1-Skp1-beta-catenin complex: destruction motif binding and lysine specificity of the SCF(beta-TrCP1) ubiquitin ligase. Mol Cell 11: 1445-1456
23. Herhaus L, Al-Salihi M, Macartney T, Weidlich S, Sapkota GP, (2013) OTUB1 enhances TGFbeta signalling by inhibiting the ubiquitylation and degradation of active SMAD2/3. Nat Commun 4: 2519
24. Shieh SY, Ikeda M, Taya Y, Prives C, (1997) DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2. Cell 91: 325-334
25. Matsumoto G, Shimogori T, Hattori N, Nukina N, (2015) TBK1 controls autophagosomal engulfment of polyubiquitinated mitochondria through p62/SQSTM1 phosphorylation. Hum Mol Genet 24: 4429-4442
26. Matsumoto G, Wada K, Okuno M, Kurosawa M, Nukina N, (2011) Serine 403 phosphorylation of p62/SQSTM1 regulates selective autophagic clearance of ubiquitinated proteins. Mol Cell 44: 279-289
27. Pilli M, Arko-Mensah J, Ponpuak M, Roberts E, Master S, Mandell MA, Dupont N, Ornatowski W, Jiang S, Bradfute SB, et al, (2012) TBK-1 promotes autophagy-mediated antimicrobial defense by controlling autophagosome maturation. Immunity 37: 223-234
28. Holt LJ, (2012) Regulatory modules: coupling protein stability to phopshoregulation during cell division. FEBS Lett 586: 2773-2777
29. Ordureau A, Smith H, Windheim M, Peggie M, Carrick E, Morrice N, Cohen P, (2008) The IRAK-catalysed activation of the E3 ligase function of Pellino isoforms induces the Lys63-linked polyubiquitination of IRAK1. Biochem J 409: 43-52
30. Rahighi S, Ikeda F, Kawasaki M, Akutsu M, Suzuki N, Kato R, Kensche T, Uejima T, Bloor S, Komander D, et al, (2009) Specific recognition of linear ubiquitin chains by NEMO is important for NF-kappaB activation. Cell 136: 1098-1109
31. Wertz IE, Dixit VM, (2010) Signaling to NF-kappaB: regulation by ubiquitination. Cold Spring Harb Perspect Biol 2: a003350
32. Deng L, Wang C, Spencer E, Yang L, Braun A, You J, Slaughter C, Pickart C, Chen ZJ, (2000) Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell 103: 351-361
33. Wang C, Deng L, Hong M, Akkaraju GR, Inoue J, Chen ZJ, (2001) TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature 412: 346-351
34. Peschard P, Ishiyama N, Lin T, Lipkowitz S, Park M, (2004) A conserved DpYR motif in the juxtamembrane domain of the Met receptor family forms an atypical c-Cbl/Cbl-b tyrosine kinase binding domain binding site required for suppression of oncogenic activation. J Biol Chem 279: 29565-29571
35. Takeda AN, Oberoi-Khanuja TK, Glatz G, Schulenburg K, Scholz RP, Carpy A, Macek B, Remenyi A, Rajalingam K, (2014) Ubiquitin-dependent regulation of MEKK2/3-MEK5-ERK5 signaling module by XIAP and cIAP1. EMBO J 33: 1784-1801
36. Lee HJ, Na K, Kwon MS, Kim H, Kim KS, Paik YK, (2009) Quantitative analysis of phosphopeptides in search of the disease biomarker from the hepatocellular carcinoma specimen. Proteomics 9: 3395-3408
37. Shiromizu T, Adachi J, Watanabe S, Murakami T, Kuga T, Muraoka S, Tomonaga T, (2013) Identification of missing proteins in the neXtProt database and unregistered phosphopeptides in the PhosphoSitePlus database as part of the Chromosome-centric Human Proteome Project. J Proteome Res 12: 2414-2421
38. Bian Y, Song C, Cheng K, Dong M, Wang F, Huang J, Sun D, Wang L, Ye M, Zou H, (2014) An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome. J Proteomics 96: 253-262
39. Zhou H, Di Palma S, Preisinger C, Peng M, Polat AN, Heck AJ, Mohammed S, (2013) Toward a comprehensive characterization of a human cancer cell phosphoproteome. J Proteome Res 12: 260-271
40. Sharma K, D'Souza RC, Tyanova S, Schaab C, Wisniewski JR, Cox J, Mann M, (2014) Ultradeep human phosphoproteome reveals a distinct regulatory nature of Tyr and Ser/Thr-based signaling. Cell Rep 8: 1583-1594
41. Ohtake F, Saeki Y, Sakamoto K, Ohtake K, Nishikawa H, Tsuchiya H, Ohta T, Tanaka K, Kanno J, (2015) Ubiquitin acetylation inhibits polyubiquitin chain elongation. EMBO Rep 16: 192-201
42. Lundby A, Secher A, Lage K, Nordsborg NB, Dmytriyev A, Lundby C, Olsen JV, (2012) Quantitative maps of protein phosphorylation sites across 14 different rat organs and tissues. Nat Commun 3: 876
43. Choudhary C, Olsen JV, Brandts C, Cox J, Reddy PN, Bohmer FD, Gerke V, Schmidt-Arras DE, Berdel WE, Muller-Tidow C, et al, (2009) Mislocalized activation of oncogenic RTKs switches downstream signaling outcomes. Mol Cell 36: 326-339
44. Manes NP, Dong L, Zhou W, Du X, Reghu N, Kool AC, Choi D, Bailey CL, Petricoin EF 3rd, Liotta LA, et al, (2011) Discovery of mouse spleen signaling responses to anthrax using label-free quantitative phosphoproteomics via mass spectrometry. Mol Cell Proteomics 10: M110 000927
45. Bennetzen MV, Larsen DH, Bunkenborg J, Bartek J, Lukas J, Andersen JS, (2010) Site-specific phosphorylation dynamics of the nuclear proteome during the DNA damage response. Mol Cell Proteomics 9: 1314-1323
46. Phanstiel DH, Brumbaugh J, Wenger CD, Tian S, Probasco MD, Bailey DJ, Swaney DL, Tervo MA, Bolin JM, Ruotti V, et al, (2011) Proteomic and phosphoproteomic comparison of human ES and iPS cells. Nat Methods 8: 821-827
47. Malik R, Lenobel R, Santamaria A, Ries A, Nigg EA, Korner R, (2009) Quantitative analysis of the human spindle phosphoproteome at distinct mitotic stages. J Proteome Res 8: 4553-4563
48. Villen J, Beausoleil SA, Gerber SA, Gygi SP, (2007) Large-scale phosphorylation analysis of mouse liver. Proc Natl Acad Sci USA 104: 1488-1493
49. Swaney DL, Rodríguez-Mias RA, Villén J, (2015) Phosphorylation of ubiquitin at Ser65 affects its polymerization, targets and proteome-wide turnover. EMBO Rep 16: 1131-1144
50. Peng J, Schwartz D, Elias JE, Thoreen CC, Cheng D, Marsischky G, Roelofs J, Finley D, Gygi SP, (2003) A proteomics approach to understanding protein ubiquitination. Nat Biotechnol 21: 921-926
51. Gu TL, Deng X, Huang F, Tucker M, Crosby K, Rimkunas V, Wang Y, Deng G, Zhu L, Tan Z, et al, (2011) Survey of tyrosine kinase signaling reveals ROS kinase fusions in human cholangiocarcinoma. PLoS One 6: e15640
52. Moritz A, Li Y, Guo A, Villen J, Wang Y, MacNeill J, Kornhauser J, Sprott K, Zhou J, Possemato A, et al, (2010) Akt-RSK-S6 kinase signaling networks activated by oncogenic receptor tyrosine kinases. Sci Signal 3: ra64
53. Rikova K, Guo A, Zeng Q, Possemato A, Yu J, Haack H, Nardone J, Lee K, Reeves C, Li Y, et al, (2007) Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer. Cell 131: 1190-1203
54. Bodenmiller B, Campbell D, Gerrits B, Lam H, Jovanovic M, Picotti P, Schlapbach R, Aebersold R, (2008) PhosphoPep-a database of protein phosphorylation sites in model organisms. Nat Biotechnol 26: 1339-1340
55. Ordureau A, Sarraf SA, Duda DM, Heo JM, Jedrychowski MP, Sviderskiy VO, Olszewski JL, Koerber JT, Xie T, Beausoleil SA, et al, (2014) Quantitative proteomics reveal a feedforward mechanism for mitochondrial PARKIN translocation and ubiquitin chain synthesis. Mol Cell 56: 360-375
56. Kane LA, Lazarou M, Fogel AI, Li Y, Yamano K, Sarraf SA, Banerjee S, Youle RJ, (2014) PINK1 phosphorylates ubiquitin to activate Parkin E3 ubiquitin ligase activity. J Cell Biol 205: 143-153
57. Kazlauskaite A, Kondapalli C, Gourlay R, Campbell DG, Ritorto MS, Hofmann K, Alessi DR, Knebel A, Trost M, Muqit MM, (2014) Parkin is activated by PINK1-dependent phosphorylation of ubiquitin at Ser65. Biochem J 460: 127-139
58. Koyano F, Okatsu K, Kosako H, Tamura Y, Go E, Kimura M, Kimura Y, Tsuchiya H, Yoshihara H, Hirokawa T, et al, (2014) Ubiquitin is phosphorylated by PINK1 to activate parkin. Nature 510: 162-166
59. Wauer T, Swatek KN, Wagstaff JL, Gladkova C, Pruneda JN, Michel MA, Gersch M, Johnson CM, Freund SM, Komander D, (2015) Ubiquitin Ser65 phosphorylation affects ubiquitin structure, chain assembly and hydrolysis. EMBO J 34: 307-325
60. Ordureau A, Heo J, Duda DM, Olszewski JL, Yanishevski D, Rinehart J, Schulman B, Harper JW, (2015) Defining roles of PARKIN and ubiquitin phosphorylation by PINK1 in mitochondrial quality control using a ubiquitin replacement strategy. Proc Natl Acad Sci USA 112: 6637-6642
61. Bondalapati S, Mansour W, Nakasone MA, Maity SK, Glickman MH, Brik A, (2015) Chemical synthesis of phosphorylated ubiquitin and diubiquitin exposes positional sensitivities of E1-E2 enzymes and deubiquitinases. Chem Eur J 21: 7360-7364
62. Okatsu K, Koyano F, Kimura M, Kosako H, Saeki Y, Tanaka K, Matsuda N, (2015) Phosphorylated ubiquitin chain is the genuine Parkin receptor. J Cell Biol 209: 111-128
63. Stolz A, Ernst A, Dikic I, (2014) Cargo recognition and trafficking in selective autophagy. Nat Cell Biol 16: 495-501
64. Youle RJ, Narendra DP, (2011) Mechanisms of mitophagy. Nat Rev Mol Cell Biol 12: 9-14
65. Kitada T, Asakawa S, Hattori N, Matsumine H, Yamamura Y, Minoshima S, Yokochi M, Mizuno Y, Shimizu N, (1998) Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392: 605-608
66. Valente EM, Abou-Sleiman PM, Caputo V, Muqit MM, Harvey K, Gispert S, Ali Z, Del Turco D, Bentivoglio AR, Healy DG, et al, (2004) Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science 304: 1158-1160
67. Pickrell AM, Youle RJ, (2015) The roles of PINK1, parkin, and mitochondrial fidelity in Parkinson's disease. Neuron 85: 257-273
68. Narendra DP, Jin SM, Tanaka A, Suen DF, Gautier CA, Shen J, Cookson MR, Youle RJ, (2010) PINK1 is selectively stabilized on impaired mitochondria to activate Parkin. PLoS Biol 8: e1000298
69. Okatsu K, Oka T, Iguchi M, Imamura K, Kosako H, Tani N, Kimura M, Go E, Koyano F, Funayama M, et al, (2012) PINK1 autophosphorylation upon membrane potential dissipation is essential for Parkin recruitment to damaged mitochondria. Nat Commun 3: 1016
70. Narendra D, Walker JE, Youle R, (2012) Mitochondrial quality control mediated by PINK1 and Parkin: links to parkinsonism. Cold Spring Harb Perspect Biol 4: a011338
71. Sarraf SA, Raman M, Guarani-Pereira V, Sowa ME, Huttlin EL, Gygi SP, Harper JW, (2013) Landscape of the PARKIN-dependent ubiquitylome in response to mitochondrial depolarization. Nature 496: 372-376
72. Kondapalli C, Kazlauskaite A, Zhang N, Woodroof HI, Campbell DG, Gourlay R, Burchell L, Walden H, Macartney TJ, Deak M, et al, (2012) PINK1 is activated by mitochondrial membrane potential depolarization and stimulates Parkin E3 ligase activity by phosphorylating Serine 65. Open Biol 2: 120080
73. Shiba-Fukushima K, Imai Y, Yoshida S, Ishihama Y, Kanao T, Sato S, Hattori N, (2012) PINK1-mediated phosphorylation of the Parkin ubiquitin-like domain primes mitochondrial translocation of Parkin and regulates mitophagy. Sci Rep 2: 1002
74. Chaugule VK, Burchell L, Barber KR, Sidhu A, Leslie SJ, Shaw GS, Walden H, (2011) Autoregulation of Parkin activity through its ubiquitin-like domain. EMBO J 30: 2853-2867
75. Trempe JF, Sauve V, Grenier K, Seirafi M, Tang MY, Menade M, Al-Abdul-Wahid S, Krett J, Wong K, Kozlov G, et al, (2013) Structure of parkin reveals mechanisms for ubiquitin ligase activation. Science 340: 1451-1455
76. Wauer T, Komander D, (2013) Structure of the human Parkin ligase domain in an autoinhibited state. EMBO J 32: 2099-2112
77. Riley BE, Lougheed JC, Callaway K, Velasquez M, Brecht E, Nguyen L, Shaler T, Walker D, Yang Y, Regnstrom K, et al, (2013) Structure and function of Parkin E3 ubiquitin ligase reveals aspects of RING and HECT ligases. Nat Commun 4: 1982
78. Kazlauskaite A, Martínez-Torres RJ, Wilkie S, Kumar A, Peltier J, Gonzalez A, Johnson C, Zhang J, Hope AG, Peggie M, et al, (2015) Binding to serine 65-phosphorylated ubiquitin primes Parkin for optimal PINK1-dependent phosphorylation and activation. EMBO Rep 16: 939-954
79. Wauer T, Simicek M, Schubert A, Komander D, (2015) Mechanism of phospho-ubiquitin-induced PARKIN activation. Nature doi: 10.1038/nature14879
80. Sauvé V, Lilov A, Seirafi M, Vranas M, Rasool S, Kozlov G, Sprules T, Wang J, Trempe JF, Gehring K, (2015) A Ubl/ubiquitin switch in the activation of Parkin. EMBO J doi: 10.15252/embj.201592237
81. Kumar A, Aguirre JD, Condos TEC, Martinez-Torres RJ, Chaugule VK, Toth R, Sundaramoorthy R, Mercier P, Knebel A, Spratt DE, et al, (2015) Disruption of the autoinhibited state primes the E3 ligase parkin for activation and catalysis. EMBO J doi: 10.15252/embj.201592337
82. Fiesel FC, Ando M, Hudec R, Hill AR, Castanedes-Casey M, Caulfield TR, Moussaud-Lamodière EL, Stankowski JN, Bauer PO, Lorenzo-Betancor O, et al, (2015) PINK1-Dependent Phosphorylation of Ubiquitin is (Patho-)Physiologically Relevant. EMBO Rep 16: 1114-1130
83. Imai Y, Kanao T, Sawada T, Kobayashi Y, Moriwaki Y, Ishida Y, Takeda K, Ichijo H, Lu B, Takahashi R, (2010) The loss of PGAM5 suppresses the mitochondrial degeneration caused by inactivation of PINK1 in Drosophila. PLoS Genet 6: e1001229
84. Lu W, Karuppagounder SS, Springer DA, Allen MD, Zheng L, Chao B, Zhang Y, Dawson VL, Dawson TM, Lenardo M, (2014) Genetic deficiency of the mitochondrial protein PGAM5 causes a Parkinson's-like movement disorder. Nat Commun 5: 4930
85. Lazarou M, Sliter DA, Kane LA, Sarraf SA, Wang C, Burman JL, Sideris DP, Fogel AI, Youle RJ, (2015) PINK1 phosphorylation of ubiquitin recruits autophagy receptors to mitochondria and upstream autophagy machinery for mitophagy. Nature doi: 10.1038/nature14893
86. Thurston TL, Ryzhakov G, Bloor S, von Muhlinen N, Randow F, (2009) The TBK1 adaptor and autophagy receptor NDP52 restricts the proliferation of ubiquitin-coated bacteria. Nat Immunol 10: 1215-1221
87. Wild P, Farhan H, McEwan DG, Wagner S, Rogov VV, Brady NR, Richter B, Korac J, Waidmann O, Choudhary C, et al, (2011) Phosphorylation of the autophagy receptor optineurin restricts Salmonella growth. Science 333: 228-233
88. Wong YC, Holzbaur EL, (2014) Optineurin is an autophagy receptor for damaged mitochondria in parkin-mediated mitophagy that is disrupted by an ALS-linked mutation. Proc Natl Acad Sci USA 111: E4439-E4448
89. Korac J, Schaeffer V, Kovacevic I, Clement AM, Jungblut B, Behl C, Terzic J, Dikic I, (2013) Ubiquitin-independent function of optineurin in autophagic clearance of protein aggregates. J Cell Sci 126: 580-592
90. Goncalves A, Burckstummer T, Dixit E, Scheicher R, Gorna MW, Karayel E, Sugar C, Stukalov A, Berg T, Kralovics R, et al, (2011) Functional dissection of the TBK1 molecular network. PLoS One 6: e23971
91. Gleason CE, Ordureau A, Gourlay R, Arthur JS, Cohen P, (2011) Polyubiquitin binding to optineurin is required for optimal activation of TANK-binding kinase 1 and production of interferon beta. J Biol Chem 286: 35663-35674
92. Cemma M, Kim PK, Brumell JH, (2011) The ubiquitin-binding adaptor proteins p62/SQSTM1 and NDP52 are recruited independently to bacteria-associated microdomains to target Salmonella to the autophagy pathway. Autophagy 7: 341-345
93. Popovic D, Vucic D, Dikic I, (2014) Ubiquitination in disease pathogenesis and treatment. Nat Med 20: 1242-1253
94. Rubino E, Rainero I, Chio A, Rogaeva E, Galimberti D, Fenoglio P, Grinberg Y, Isaia G, Calvo A, Gentile S, et al, (2012) SQSTM1 mutations in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Neurology 79: 1556-1562
95. Shen WC, Li HY, Chen GC, Chern Y, Tu PH, (2015) Mutations in the ubiquitin-binding domain of OPTN/optineurin interfere with autophagy-mediated degradation of misfolded proteins by a dominant-negative mechanism. Autophagy 11: 685-700
96. Menzies FM, Fleming A, Rubinsztein DC, (2015) Compromised autophagy and neurodegenerative diseases. Nat Rev Neurosci 16: 345-357
97. Pottier C, Bieniek KF, Finch N, van de Vorst M, Baker M, Perkersen R, Brown P, Ravenscroft T, van Blitterswijk M, Nicholson AM, et al, (2015) Whole-genome sequencing reveals important role for TBK1 and OPTN mutations in frontotemporal lobar degeneration without motor neuron disease. Acta Neuropathol 130: 77-92
98. Freischmidt A, Wieland T, Richter B, Ruf W, Schaeffer V, Muller K, Marroquin N, Nordin F, Hubers A, Weydt P, et al, (2015) Haploin-sufficiency of TBK1 causes familial ALS and fronto-temporal dementia. Nat Neurosci 18: 631-636
99. Cirulli ET, Lasseigne BN, Petrovski S, Sapp PC, Dion PA, Leblond CS, Couthouis J, Lu YF, Wang Q, Krueger BJ, et al, (2015) Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways. Science 347: 1436-1441
100. Kazlauskaite A, Muqit MM, (2015) PINK1 and Parkin-mitochondrial interplay between phosphorylation and ubiquitylation in Parkinson's disease. FEBS J 282: 215-223
101. Fiesel FC, Caulfield TR, Moussaud-Lamodiere EL, Dourado KO, Flores SC, Ross OA, Springer W, (2015) Structural and functional impact of Parkinson disease-associated mutations in the E3 ubiquitin ligase Parkin. Hum Mutat 36: 774-786
102. Pickrell AM, Huang CH, Kennedy SR, Ordureau A, Sideris DP, Hoekstra JG, Harper JW, Youle RJ, (2015) Endogenous Parkin preserves dopaminergic substantia nigral neurons following mitochondrial DNA mutagenic stress. Neuron 87: 371-381
103. Yun J, Puri R, Yang H, Lizzio MA, Wu C, Sheng ZH, Guo M, (2014) MUL1 acts in parallel to the PINK1/parkin pathway in regulating mitofusin and compensates for loss of PINK1/parkin. eLife 3: e01958
104. Ambivero CT, Cilenti L, Main S, Zervos AS, (2014) Mulan E3 ubiquitin ligase interacts with multiple E2 conjugating enzymes and participates in mitophagy by recruiting GABARAP. Cell Signal 26: 2921-2929
105. Muller-Rischart AK, Pilsl A, Beaudette P, Patra M, Hadian K, Funke M, Peis R, Deinlein A, Schweimer C, Kuhn PH, et al, (2013) The E3 ligase parkin maintains mitochondrial integrity by increasing linear ubiquitination of NEMO. Mol Cell 49: 908-921
106. Alessi DR, Cuenda A, Cohen P, Dudley DT, Saltiel AR, (1995) PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J Biol Chem 270: 27489-27494
107. Rogerson DT, Sachdeva A, Wang K, Haq T, Kazlauskaite A, Hancock SM, Huguenin-Dezot N, Muqit MM, Fry AM, Bayliss R, et al, (2015) Efficient genetic encoding of phosphoserine and its nonhydrolyzable analog. Nat Chem Biol 11: 496-503
108. Park HS, Hohn MJ, Umehara T, Guo LT, Osborne EM, Benner J, Noren CJ, Rinehart J, Soll D, (2011) Expanding the genetic code of Escherichia coli with phosphoserine. Science 333: 1151-1154
109. Han C, Pao KC, Kazlauskaite A, Muqit MM, Virdee S, (2015) A versatile strategy for the semisynthetic production of Ser65 phosphorylated ubiquitin and its biochemical and structural characterization. ChemBioChem 16: 1574-1579
110. Ordureau A, Munch C, Harper JW, (2015) Quantifying ubiquitin signaling. Mol Cell 58: 660-676
111. Choudhary C, Weinert BT, Nishida Y, Verdin E, Mann M, (2014) The growing landscape of lysine acetylation links metabolism and cell signalling. Nat Rev Mol Cell Biol 15: 536-550
112. Choudhary C, Kumar C, Gnad F, Nielsen ML, Rehman M, Walther TC, Olsen JV, Mann M, (2009) Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science 325: 834-840
113. Robinson NE, Robinson AB, (2008) Use of Merrifield solid phase peptide synthesis in investigations of biological deamidation of peptides and proteins. Biopolymers 90: 297-306
114. Washington EJ, Banfield MJ, Dangl JL, (2013) What a difference a Dalton makes: bacterial virulence factors modulate eukaryotic host cell signaling systems via deamidation. Microbiol Mol Biol Rev 77: 527-539
115. Cui J, Yao Q, Li S, Ding X, Lu Q, Mao H, Liu L, Zheng N, Chen S, Shao F, (2010) Glutamine deamidation and dysfunction of ubiquitin/NEDD8 induced by a bacterial effector family. Science 329: 1215-1218
116. Yao Q, Cui J, Wang J, Li T, Wan X, Luo T, Gong YN, Xu Y, Huang N, Shao F, (2012) Structural mechanism of ubiquitin and NEDD8 deamidation catalyzed by bacterial effectors that induce macrophage-specific apoptosis. Proc Natl Acad Sci USA 109: 20395-20400
117. Lydeard JR, Schulman BA, Harper JW, (2013) Building and remodelling Cullin-RING E3 ubiquitin ligases. EMBO Rep 14: 1050-1061
118. Petroski MD, Deshaies RJ, (2005) Function and regulation of cullin-RING ubiquitin ligases. Nat Rev Mol Cell Biol 6: 9-20
119. Skaar JR, Pagan JK, Pagano M, (2014) SCF ubiquitin ligase-targeted therapies. Nat Rev Drug Discovery 13: 889-903
120. Tanaka T, Nakatani T, Kamitani T, (2012) Inhibition of NEDD8-conjugation pathway by novel molecules: potential approaches to anticancer therapy. Mol Oncol 6: 267-275
121. Striebel F, Imkamp F, Sutter M, Steiner M, Mamedov A, Weber-Ban E, (2009) Bacterial ubiquitin-like modifier Pup is deamidated and conjugated to substrates by distinct but homologous enzymes. Nat Struct Mol Biol 16: 647-651